leisure time -WSS

leisure time

author：entertainment 2025-09-29 20:51:38 - browse：48328

Without question, the new federal law banning surprise billing is achieving its goal of protecting patients from enormous medical bills. But in doing so, the measure, which was initially projected to lower federal spending, appears to be raising costs elsewhere.

The Biden administration’s new progress report on the process for arbitrating disagreements between insurance companies and providers, which covers the first six months of 2023, shows that in over 80% of payment disputes, the arbiter settled on an amount that was more than the median in-network rate for that service. In other words, insurers were ordered to pay more to an out-of-network provider than they’d pay to a contracted one. Not only that, the sheer volume of disputes means the three federal agencies that run the program are devoting much more time to it than expected.

“It raises concerns for folks that envisioned the arbitration process as helping to moderate costs rather than be a tool these companies can leverage to obtain even higher payments,” said Zachary Baron, the director of Georgetown University’s Health Policy and Law Initiative.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： CVS is on a mission to consolidate health care. Will it work?

WSS

A pediatrician calls for Congress to pass the child tax credit deal

Louisiana bill approved classifying abortion pills as controlled substances

U.S. death rates show how politics are affecting public health

FDA endorses new sterilization method for medical devices

CVS is on a mission to consolidate health care. Will it work?

Unmasking the 'centricity' illusion in clinical trials

explore

leisure time

hotspot

Dobbs anniversary: the lost opportunity of abortion as health care

Cardiologists urge adding sexual orientation, gender identity to health records

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

Duchenne breakthrough therapy leaves behind pioneering families

HPV vaccine, cervical cancer study delivers historic results

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Update the Apgar Score to remove skin color

Cancer drug shortages should be causing more outrage

Medical students need to learn the potent medicine of empathy

knowledge

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

New research sheds light on how often breast cancer is overdiagnosed

Inaction leaves children at risk from dangerous chemotherapy drug

Mass General, Mayo Clinic look to monetize custom

TikTok, Instagram influencers need more rules for drug ads

HPV vaccine, cervical cancer study delivers historic results

hotspot

explore

entertainment

entertainment